Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 2:13:850955.
doi: 10.3389/fpsyt.2022.850955. eCollection 2022.

Anti-Neuronal Autoantibodies (Cell Surface and Onconeural) and Their Association With Natural Autoantibodies in Synthetic Cannabinoid-Induced Psychosis

Lídia Hau  1 , Tamás Tényi  2 , Natália László  1 , Márton Áron Kovács  2 , Szabina Erdö-Bonyár  3 , Zsuzsanna Csizmadia  3 , Tímea Berki  3 , Diána Simon  3 , Györgyi Csábi  1
Affiliations

Anti-Neuronal Autoantibodies (Cell Surface and Onconeural) and Their Association With Natural Autoantibodies in Synthetic Cannabinoid-Induced Psychosis

Lídia Hau et al. Front Psychiatry. .

Abstract

Patients suffering from encephalitis may present psychiatric symptoms; however, the clinical relevance of anti-neuronal antibodies in patients experiencing a psychotic episode without encephalitis is still unclear. In this study, we examined the presence of anti-neuronal cell surface autoantibodies and onconeural autoantibodies in serum samples of 22 synthetic cannabinoid users presenting with psychosis. We found only two positive cases; however, seven patients had borderline results. Nonetheless, we found no significant correlation between anti-neuronal autoantibodies and the intensity of psychosis indicated by the Positive and Negative Syndrome Scale (PANSS) scores. The length of drug use and the combination of other drugs with synthetic cannabinoids have no significant effect on anti-neuronal autoantibody positivity. Nonetheless, the ratio of anti-citrate synthase (anti-CS) IgM and IgG natural autoantibodies was significantly lower (p = 0.036) in the anti-neuronal autoantibody-positive/borderline samples, than in the negative group. Interestingly, anti-CS IgM/IgG showed a significant negative correlation with PANSS-positive score (p = 0.04, r = -0.464). Our results demonstrated that anti-neuronal autoantibody positivity occurs in synthetic cannabinoid users, and the alteration of anti-CS IgM/IgG natural autoantibody levels points to immunological dysfunctions in these cases.

Keywords: anti-citrate synthase antibodies; anti-neuronal autoantibodies; autoimmune encephalitis; natural autoantibodies; psychosis; synthetic cannabinoid.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The level of anti-citrate synthase (CS) IgM (A), IgG (B), and autoantibodies and their ratio (C) in patients with positive/borderline (n = 8) and negative (n = 14) results for anti-neuronal autoantibodies. The boxes show interquartile ranges (IQR); the horizontal lines represent medians and the whiskers indicate the lowest and highest values. *p < 0.05.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Runge K, Fiebich BL, Kuzior H, Saliba SW, Yousif NM, Meixensberger S, et al. . An observational study investigating cytokine levels in the cerebrospinal fluid of patients with schizophrenia spectrum disorders. Schizophr Res. (2021) 231:205–13. 10.1016/j.schres.2021.03.022 - DOI - PubMed
    1. Hau L, Csábi G, Tényi T. Anti-N-methyl-D aspartate receptor encephalitis - guideline to the challenges of diagnosis and therapy. Psychiatr Hung. (2015) 30:402–8. - PubMed
    1. Pollak TA, Beck K, Irani SR, Howes OD, David AS, McGuire PK. Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications. Psychopharmacology (Berl). (2016) 233:1605–21. 10.1007/s00213-015-4156-y - DOI - PMC - PubMed
    1. Ezeoke A, Mellor A, Buckley P, Miller B. A systematic, quantitative review of blood autoantibodies in schizophrenia. Schizophr Res. (2013) 150:245–51. 10.1016/j.schres.2013.07.029 - DOI - PubMed
    1. Buckley C, Oger J, Clover L, Tüzün E, Carpenter K, Jackson M, et al. . Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol. (2001) 50:73–8. 10.1002/ana.1097 - DOI - PubMed

LinkOut - more resources